Literature DB >> 24662731

Prostate cancer: Melbourne consensus-noble but misguided.

Hashim U Ahmed1.   

Abstract

Unfortunately, the noble aims of the Melbourne Consensus statement on the early detection of prostate cancer lack rigour, failing to take into account the breadth of evidence in this field; as a result, they fall disappointingly short of providing clarity on this important issue.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24662731     DOI： 10.1038/nrurol.2014.65

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


  10 in total

Review 1.  The Melbourne Consensus Statement on the early detection of prostate cancer.

Authors:  Declan G Murphy; Thomas Ahlering; William J Catalona; Helen Crowe; Jane Crowe; Noel Clarke; Matthew Cooperberg; David Gillatt; Martin Gleave; Stacy Loeb; Monique Roobol; Oliver Sartor; Tom Pickles; Addie Wootten; Patrick C Walsh; Anthony J Costello
Journal:  BJU Int       Date:  2014-02       Impact factor: 5.588

2.  Radical prostatectomy versus observation for localized prostate cancer.

Authors:  Timothy J Wilt; Michael K Brawer; Karen M Jones; Michael J Barry; William J Aronson; Steven Fox; Jeffrey R Gingrich; John T Wei; Patricia Gilhooly; B Mayer Grob; Imad Nsouli; Padmini Iyer; Ruben Cartagena; Glenn Snider; Claus Roehrborn; Roohollah Sharifi; William Blank; Parikshit Pandya; Gerald L Andriole; Daniel Culkin; Thomas Wheeler
Journal:  N Engl J Med       Date:  2012-07-19       Impact factor: 91.245

3.  Mortality results from the Göteborg randomised population-based prostate-cancer screening trial.

Authors:  Jonas Hugosson; Sigrid Carlsson; Gunnar Aus; Svante Bergdahl; Ali Khatami; Pär Lodding; Carl-Gustaf Pihl; Johan Stranne; Erik Holmberg; Hans Lilja
Journal:  Lancet Oncol       Date:  2010-07-02       Impact factor: 41.316

4.  Prostate-cancer mortality at 11 years of follow-up.

Authors:  Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Hans Lilja; Marco Zappa; Louis J Denis; Franz Recker; Alvaro Páez; Liisa Määttänen; Chris H Bangma; Gunnar Aus; Sigrid Carlsson; Arnauld Villers; Xavier Rebillard; Theodorus van der Kwast; Paula M Kujala; Bert G Blijenberg; Ulf-Hakan Stenman; Andreas Huber; Kimmo Taari; Matti Hakama; Sue M Moss; Harry J de Koning; Anssi Auvinen
Journal:  N Engl J Med       Date:  2012-03-15       Impact factor: 91.245

5.  National Institutes of Health State-of-the-Science Conference: role of active surveillance in the management of men with localized prostate cancer.

Authors:  Patricia A Ganz; John M Barry; Wylie Burke; Nananda F Col; Phaedra S Corso; Everett Dodson; M Elizabeth Hammond; Barry A Kogan; Charles F Lynch; Lee Newcomer; Eric J Seifter; Janet A Tooze; Kasisomayajula Viswanath; Hunter Wessells
Journal:  Ann Intern Med       Date:  2012-02-20       Impact factor: 25.391

Review 6.  Screening for prostate cancer.

Authors:  Dragan Ilic; Molly M Neuberger; Mia Djulbegovic; Philipp Dahm
Journal:  Cochrane Database Syst Rev       Date:  2013-01-31

7.  Long-term functional outcomes after treatment for localized prostate cancer.

Authors:  Matthew J Resnick; Tatsuki Koyama; Kang-Hsien Fan; Peter C Albertsen; Michael Goodman; Ann S Hamilton; Richard M Hoffman; Arnold L Potosky; Janet L Stanford; Antoinette M Stroup; R Lawrence Van Horn; David F Penson
Journal:  N Engl J Med       Date:  2013-01-31       Impact factor: 91.245

8.  Multiparametric magnetic resonance imaging findings in men with low-risk prostate cancer followed using active surveillance.

Authors:  Jeffrey K Mullins; David Bonekamp; Patricia Landis; Hosne Begum; Alan W Partin; Jonathan I Epstein; H Ballentine Carter; Katarzyna J Macura
Journal:  BJU Int       Date:  2013-03-06       Impact factor: 5.588

Review 9.  Do low-grade and low-volume prostate cancers bear the hallmarks of malignancy?

Authors:  Hashim Uddin Ahmed; Manit Arya; Alex Freeman; Mark Emberton
Journal:  Lancet Oncol       Date:  2012-11       Impact factor: 41.316

10.  The changing face of low-risk prostate cancer: trends in clinical presentation and primary management.

Authors:  Matthew R Cooperberg; Deborah P Lubeck; Maxwell V Meng; Shilpa S Mehta; Peter R Carroll
Journal:  J Clin Oncol       Date:  2004-06-01       Impact factor: 44.544
  10 in total
  2 in total

1.  Prostate cancer: active surveillance may prove organisationally impossible.

Authors:  W P Tormey
Journal:  Ir J Med Sci       Date:  2015-03-05       Impact factor: 1.568

2.  Tissue ACE phenotyping in prostate cancer.

Authors:  Sergei M Danilov; Alexey V Kadrev; Olga V Kurilova; Victoria E Tikhomirova; Olga V Kryukova; Vadim N Mamedov; David M Kamalov; Natalia V Danilova; Dmitry A Okhobotov; Nurshat M Gayfullin; Valery V Evdokimov; Boris J Alekseev; Olga A Kost; Larisa M Samokhodskaya; Armais A Kamalov
Journal:  Oncotarget       Date:  2019-10-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.